Skip to content
PubMed This is a summary of 10 peer-reviewed journal articles Updated
Medical Genetics

Subtypes, Genetics, and the St. George's Algorithm

At a Glance

Primary lymphedema is often caused by genetic mutations that affect how lymphatic vessels develop. Doctors use the St. George's algorithm and genetic testing to classify the specific subtype, which helps tailor treatment and screen for related health conditions.

When you are diagnosed with primary lymphedema, your doctor may use specific terms and “algorithms” to categorize your condition. While these can sound complicated, they are actually powerful tools that help specialists move beyond just treating the swelling to understanding the underlying “blueprint” error in your lymphatic system.

The Timing of Your Symptoms

Doctors first categorize primary lymphedema by when the swelling first appeared. This is more than just a label; the timing often points toward which genes might be involved [1].

  • Congenital Lymphedema: Swelling is present at birth or appears within the first year of life [1]. This is often bilateral (affecting both legs) and is frequently linked to the FLT4 gene [2][3].
  • Lymphedema Praecox: The most common form, appearing between age 1 and 35, often triggered by puberty [1].
  • Lymphedema Tarda: Onset occurs after age 35 [1]. This type is usually milder, often affects only one leg, and is less likely to be passed down through families than the earlier-onset forms [4].

The St. George’s Classification Algorithm

To provide a more precise diagnosis, many specialists use the St. George’s classification algorithm [5]. Think of this as a medical “decision tree” that helps doctors sort patients into groups based on their symptoms [6].

The algorithm looks at:

  1. Is it “syndromic”? Does the swelling happen alongside other health issues, such as heart defects, hearing loss, or unusual facial features? [6]
  2. Is it isolated? Is the swelling the only symptom? [6]
  3. What does the imaging show? Using tests like lymphoscintigraphy, doctors see if your lymphatic vessels are missing (aplasia) or just underdeveloped (hypoplasia) [1][7].

This structured approach is important because different subtypes respond differently to treatments and may require screening for other “hidden” health issues [8].

Key Genetic Mutations and Syndromes

We now know that primary lymphedema is often caused by a “misspelling” in the DNA that controls how lymphatic vessels grow [9][2]. Some of the most common genetic connections include:

  • Milroy Disease (FLT4 mutation): Typically causes swelling from birth. It is a “non-syndromic” form, meaning the swelling is usually the only major symptom [2][3].
  • Lymphedema-Distichiasis Syndrome (FOXC2 mutation): In addition to leg swelling (usually starting in puberty), people with this mutation grow an extra row of eyelashes (distichiasis) [9][10]. They may also have early-onset varicose veins.
  • Emberger Syndrome (GATA2 mutation): This is a more complex condition where lymphedema is associated with low white blood cell counts and a higher risk of developing certain blood disorders [9].

The Value of Genetic Testing

In the past, doctors could only guess at the cause of primary lymphedema. Today, genetic testing can provide a definitive answer for many patients. Recent research shows that specialized genetic panels can find a clear molecular cause in about 26% to 41% of patients [6][9].

Understanding Your Risks: It is crucial to understand that many lymphatic mutations have what is called incomplete penetrance. This means that even if a genetic mutation is identified as “autosomal dominant” (meaning there is a 50% chance of passing the gene to a child), it does not guarantee the child will ever develop symptoms or swelling [9].

Because learning about genetic risks can be overwhelming, working with a genetic counselor is highly recommended. They can help you navigate these feelings, understand the nuances of your specific mutation, and make informed choices about your family planning and long-term care [9].

Common questions in this guide

What is the St. George's algorithm for primary lymphedema?
The St. George's algorithm is a medical decision tree that helps doctors categorize primary lymphedema based on your symptoms and imaging results. It helps determine if your swelling is isolated or part of a broader genetic syndrome.
What is the difference between lymphedema praecox and lymphedema tarda?
Lymphedema praecox is the most common form and typically appears between age 1 and 35, often triggered by puberty. Lymphedema tarda begins after age 35, is usually milder, and is less likely to be passed down through families.
Should I get genetic testing for my primary lymphedema?
Genetic testing can identify a clear underlying cause in roughly 26% to 41% of patients with primary lymphedema. Identifying a specific mutation can help tailor your treatment plan and determine if you need screening for other health issues.
What does it mean if my lymphedema is syndromic?
Syndromic primary lymphedema means your swelling occurs alongside other health conditions caused by the same genetic mutation. This could include issues like heart defects, hearing loss, or extra eyelashes that require separate monitoring.
If I have a genetic mutation for lymphedema, will my children get it?
Not necessarily. Many lymphedema genes have incomplete penetrance, which means that even if a child inherits the mutation, they may never actually develop swelling or symptoms. A genetic counselor can help clarify your specific family risks.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Which pathway of the St. George’s algorithm does my presentation fall into (e.g., syndromic vs. non-syndromic)?
  2. 2.Based on the timing of my symptoms, am I classified as having Congenital, Praecox, or Tarda lymphedema?
  3. 3.Should I have a genetic test panel for FLT4 and FOXC2, and what would the 'diagnostic yield' (likelihood of an answer) be for me?
  4. 4.If a genetic mutation is found, what other systemic health issues (like heart or lung problems) should we screen for?
  5. 5.How does knowing my specific genetic subtype change my treatment plan or surgical options?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (10)
  1. 1

    Primary lymphedema French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins).

    Vignes S, Albuisson J, Champion L, et al.

    Orphanet journal of rare diseases 2021; (16(1)):18 doi:10.1186/s13023-020-01652-w.

    PMID: 33407666
  2. 2

    Identification of a Novel FLT4 c.3028A>C Variant Associated With Milroy Disease.

    Feiskhanov A, Ibragimova A, Gaysina E, et al.

    Clinical genetics 2025; (107(5)):541-546 doi:10.1111/cge.14671.

    PMID: 39691059
  3. 3

    Surgical treatment of Milroy disease.

    Bolletta A, Di Taranto G, Chen SH, et al.

    Journal of surgical oncology 2020; (121(1)):175-181 doi:10.1002/jso.25583.

    PMID: 31165487
  4. 4

    Adult-Onset Primary Lymphedema: A Clinical-Lymphoscintigraphic Study of 26 Patients.

    Goss JA, Maclellan RA, Greene AK

    Lymphatic research and biology 2019; (17(6)):620-623 doi:10.1089/lrb.2018.0032.

    PMID: 30916606
  5. 5

    The St George's Classification Algorithm of Primary Lymphatic Anomalies.

    Gordon K, Mortimer PS, van Zanten M, et al.

    Lymphatic research and biology 2021; (19(1)):25-30 doi:10.1089/lrb.2020.0104.

    PMID: 33395557
  6. 6

    Update and audit of the St George's classification algorithm of primary lymphatic anomalies: a clinical and molecular approach to diagnosis.

    Gordon K, Varney R, Keeley V, et al.

    Journal of medical genetics 2020; (57(10)):653-659 doi:10.1136/jmedgenet-2019-106084.

    PMID: 32409509
  7. 7

    Lymphoscintigraphic Abnormalities Associated with Milroy Disease and Lymphedema-Distichiasis Syndrome.

    Sarica M, Gordon K, van Zanten M, et al.

    Lymphatic research and biology 2019; (17(6)):610-619 doi:10.1089/lrb.2019.0016.

    PMID: 31721633
  8. 8

    Genetic causes of lymphatic disorders: recent updates on the clinical and molecular aspects of lymphatic disease.

    Bowman C, Rockson SG

    Current opinion in cardiology 2024; (39(3)):170-177 doi:10.1097/HCO.0000000000001116.

    PMID: 38483006
  9. 9

    Current Concepts in the Management of Primary Lymphedema.

    Senger JB, Kadle RL, Skoracki RJ

    Medicina (Kaunas, Lithuania) 2023; (59(5)) doi:10.3390/medicina59050894.

    PMID: 37241126
  10. 10

    Microdeletion of 16q24.1-q24.2-A unique etiology of Lymphedema-Distichiasis syndrome and neurodevelopmental disorder.

    Michelson M, Lidzbarsky G, Nishri D, et al.

    American journal of medical genetics. Part A 2022; (188(7)):1990-1996 doi:10.1002/ajmg.a.62730.

    PMID: 35312147

This page provides educational information about primary lymphedema genetics and classification. It does not replace professional medical evaluation or personalized genetic counseling.

Get notified when new evidence is published on Primary lymphedema.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.